Our study investigated the potential of serum IL-35 as a biomarker for ovarian tumors. However, we did not find a significant difference in serum IL-35 levels between patients and healthy controls, nor did we find any significant correlations…
Role of serum IL-35 levels in patients with benign and malignant primary ovarian tumors: a case-control study
